Abacavir/Lamivudine Milpharm

Abacavir/Lamivudine Milpharm is a combination medication used in the treatment of HIV infection. This oral medication helps manage the virus by reducing its ability to multiply in the body.

Abacavir/Lamivudine Milpharm is primarily used in the treatment of HIV-1 infection. This combination therapy is designed to help control the virus, allowing the immune system to function more effectively. It is often prescribed as part of a broader antiretroviral regimen to manage HIV. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of Abacavir/Lamivudine Milpharm may include headaches, nausea, and fatigue. Some individuals might experience dizziness or insomnia. These effects vary among users and are not exhaustive. Always consult a healthcare professional for personalized advice.

Abacavir/Lamivudine Milpharm should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of liver disease or hepatitis should discuss this with their doctor before starting this medication. Always store the medication as directed to maintain its efficacy.

Abacavir/Lamivudine Milpharm may interact with other medications, including certain antiretrovirals and drugs metabolized by the liver. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of this medication.